The FGF-BP2 Polyclonal Antibody (PACO09286) is a valuable tool for researchers studying FGF-BP2, a key protein involved in the regulation of fibroblast growth factor (FGF) signaling pathways. This antibody, produced in rabbits, exhibits high specificity and sensitivity to FGF-BP2 in human samples, making it a reliable choice for Western blot analysis.FGF-BP2, also known as FGF binding protein 2, is known to interact with FGF ligands to modulate their activity in cell signaling processes.
Dysregulation of FGF-BP2 has been implicated in various diseases, including cancer and metabolic disorders, highlighting its potential as a therapeutic target. The FGF-BP2 Polyclonal Antibody enables researchers to investigate the expression and function of FGF-BP2 in different cell types and biological contexts, providing valuable insights for drug development and disease intervention strategies.
fibroblast growth factor binding protein 2;FGFBP2;HBP17RP;KSP37 ;
NCBI Summary:
This gene encodes a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma.[provided by RefSeq Staff, Oct 2008]
